Consortium

Under construction:

The consortium is composed of six European partners

INRIA (Montpellier, France) as the coordinator
INRIA is the french National Institute for Research in Digital Science and Technology.
The project is coordinated by Christine Azevedo, a Senior Research Scientist in Movement automatic-control and robotics. Christine is leading the CAMIN team (Control of Artificial Movement & Intuitive Neuroprosthesis) of the Inria Centre at Université Côte d’Azur.

NEURINNOV (Montpellier, France)
Neurinnov, a developer of advanced neurostimulation solutions applicable across a broad spectrum of pathologies, is aimed to enable patients living with complete spinal cord injury to regain essential hand grasping functions and greater autonomy. Neurinnov is addressing an unmet need in underserved populations, where every year an estimated 22 million people suffer from spinal cord injury, with 2.5 million resulting in paralysis.
The company is perfecting a nerve stimulation solution that can induce selective activation of targeted muscles by steering electrical currents exclusively through one or set of nerves. This small form factor implantable device will offer significant advantages. It is the first to trigger muscle activation through ‘selective’ neural stimulation and demonstrate how patients with complete tetraplegia will perform everyday functions, such as eating with a fork, and bring their paralyzed upper limbs to life.

Centre Bouffard-Vercelli USSAP (Perpignan, France), a rehabilitation center member of the French health and social union for support and prevention. The team is leaded by Dr Charles Fattal (MD Physical Medicine). to be updated

Rehazenter (Luxemburg), officially known as the Centre National de Rééducation Fonctionnelle et de Réadaptation, is designed to improve the quality of life of its patients with respect and expertise. The Center is equipped with modern facilities including therapy rooms, hospitalization units, a pool, a gym, outdoor areas, an auditorium, and accommodation options for both inpatients and outpatients, underscoring its commitment to multidisciplinary care. The competences of the RehaLAB related to clinical trials, rehabilitation of neurological diseases using intensive programs and innovative technologies, are relevant for the AI-HAND project.

The Albert-Ludwigs-Universitaet Freiburg (Germany) with its Laboratory for Biomedical Microtechnology (https://www.imtek.de/laboratories/biomedical-microtechnology/bm_home?set_language=en). The team is leaded by Prof. Dr.-Ing. Thomas Stieglitz who contributes with his expertise on flexible neural electrode and implant development. The laboratory is run under an ISO 13485 quality management system and focus on reliability and longevity of neural implants.

CorTec neuro (Freiburg, Germany), was founded in 2011 with the idea to develop a novel implantable system to treat neurological conditions. CorTec neuro invented the Brain Interchange System. With this active implantable device the company is able to read from the brain, adjust the treatment of neurological conditions according to the current situation of the patient, and then apply electrical stimulation to the brain – writing into the brain. Currently available device can only “write” into the brain. CorTec neuro provides solutions for the communication with the nervous system—to enable customers to develop novel and effective medical devices. Passionate about providing new perspectives on the treatment of neurological diseases. By collaborating at the interface of biology and technology, the company is devoted to delivering the finest solutions—for researchers, industry, clinicians, and patients. With this technology they have the potential to make an impact on peoples’ lives. More information on their LinkedIn account https://www.linkedin.com/company/cortec-gmbh. Contact addresses : Info@cortec-neuro.com for general information and sales@cortec-neuro.com for product inquiries.

Three external partners are also involved in the project:

Clinique St Jean Orthosud (Montpellier, France), leaded by Drs Jacques Teissier and Benjamin DeGeorge orthopaedic surgeons to be updated